First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan

/PRNewswire/ -- The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of...

Related Keywords

United States ,Japan ,Boston ,Massachusetts ,Japanese ,Monica Kleinman ,Francis Collins ,Audrey Gordon ,Progeroid Laminopathies ,Sam Berns ,Leslie Gordon ,Genetic Base Editing ,National Institutes Of Health ,Cell Tissue Bank ,Research Database ,International Patient Registry ,Progeria International Patient Registry ,Progeria Research Foundation ,Diagnostics Testing Program ,Japanese Ministry Of Health ,Drug Administration ,European Medicines Administration ,Receives Japanese Approval ,Processing Deficient Progeroid ,Japanese Ministry ,Patient Registry ,Boston Children ,Without Zokinvy ,Executive Director ,Progeria Research ,Zokinvy Clinical Trial ,National Institutes ,Tissue Bank ,Clinical Care Handbook ,Principal Investigator ,Hutchinson Gilford Progeria Syndrome ,Acting Science Advisor ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Children ,Diversity ,Quity Amp Inclusion ,